Avner Ingerman

Advanced Viral Research Corp. is a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company was founded in July 1985 and is headquartered in Yonkers, NY.

Net2Phone, Inc. engages in the provision of voice-enhanced internet communications services. It offers business messaging, international calling, additional offerings, api integration, analytics, call blocking, call recording, chrome extension, company directory, live chat, mobile app, net2phojne portal, on hold options, ring groups, web calling, and voicemail options. The company was founded in 1996 and is headquartered in Newark, NJ.

Mystic Pharmaceuticals, Inc. manufactures and wholesales pharmaceutical and biological products. The private company was founded in 2003 and is based in Austin, TX.

Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA.

Skadden, Arps, Slate, Meagher & Flom LLP provides legal advisory services. Its practice areas include mergers and acquisitions, finance, litigation, corporate finance, insurance, tax, labor and employment, political law, private equity, corporate, antitrust, white collar crime, international, regulatory, and legislation. The company was founded by Marshall Skadden, John Slate, and Les Arps in 1948 and is headquartered in New York, NY.

National Italian American Foundation (NIAF) provides education and careers to Italian Americans. It provides services through the development of educational programs, advocacy of representation in government, monitoring how Italians and Italian-Americans are depicted in the media and the forging of ties between the United States and Italy. the firm also offers scholarships for Italian-American students and for students emarking on Italian-based studies. NIAF was founded in 1975 and is headquartered at Washington, DC.

Enerpulse, Inc. designs, develops, and markets automotive spark plugs. The company's product, PULSTAR Pulse Plug, uses an integrated capacitor that stores and compresses electrical energy to intensify the ignition spark in internal combustion engines. The company was founded by Lou Camilli on January 22, 2004 and is headquartered in Albuquerque, NM.

Regal Bank provides commercial banking services. The firm offers personal banking, business banking and online services. It also provides retirement savings, calculators, mortgage and commercial loans. The company was founded in 2007 and is headquartered in Livingston, NJ.

DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY.

Friends of Jerusalem College of Technology Ltd. is a national, not-for-profit 501 (c)(3) charitable organization that aims to bridge the passions of Americans to the academic endeavors of the College of Technology, one of Israel's most prestigious technological institutions. The non-profit company is based in Jerusalem, Israel. The College of Technology's students have designed life-changing innovations such as a system of sensors to inform first-responders if they possess faulty or missing equipment in the back of their ambulances before responding to a life-threatening crisis. Additionally, the students have designed a medic checklist app during a hackathon and created entrepreneurial medical devices using machine learning to automatically detect the images of patients. The organization was founded in 1976.

Part of EOM Pharmaceuticals Holdings, Inc., EOM Pharmaceuticals, Inc. is a privately held, clinical-stage company focused on developing novel drugs to improve the quality of life for patients with debilitating and sometimes deadly diseases. The company is based in Montvale, NJ. The company's mission is to pursue innovative approaches with small molecule therapeutics to address urgent and unmet medical needs. EOM's pipeline includes the development of the first-and-only dual-acting, broad-spectrum immunomodulator EOM613, which has the potential to treat systemic illnesses caused by intense inflammatory immune reactions, including COVID-19, influenza, and cancer cachexia. Additionally, EOM is working on an advanced formulation of EOM147, the first potential topically administered eye drop for treating retinal diseases. The company was founded by Shalom Z. Hirschman and Eli Goldberger, and Irach B. Taraporewala has been the CEO since 2020. EOM Pharmaceuticals was acquired by ImmunoCellular Therapeutics Ltd. on December 02, 2021.